Literature DB >> 2144467

Demonstration of a splenic cytotoxic effector cell in mice of genotype SCID/SCID.BG/BG.

J R MacDougall1, B A Croy, C Chapeau, D A Clark.   

Abstract

Splenocytes from mice of genotype scid/scid.bg/bg were tested in vitro to characterize the nature of the immunological deficit in these doubly mutant animals. The cells were unresponsive to the mitogens LPS and Con A and to alloantigens, as predicted for scid/scid genotype. Splenocytes from scid/scid.bg/bg lysed the NK cell-sensitive target cell line YAC at levels approximately 50% lower than those observed for scid/scid splenocytes. Splenocytes from SCID-beige mice failed to lyse the NK-resistant, LAK-sensitive cell line P815 but showed high levels of activity against the murine placental cell line Be6. Lytic activity was found in both nonadherent and plastic adherent cells and was eliminated by pretreatment of the effectors with anti-asialo-GM1 and complement. Incubation of 1 x 10(5) splenocytes with hrIL-2 failed to induce blastogenesis in scid/scid.bg/bg cells but produced a response in cultures of scid/scid or bg/bg spleen cells. However, blastogenesis and elevated levels of LAK-type killing were observed following incubation of higher numbers of scid/scid.bg/bg splenocytes in hrIL-2. Thus, doubly mutant scid/scid.bg/bg mice have reduced NK cell activity, in comparison to scid/scid mice, and appear to possess LAK-like effector cells and LAK cell precursors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2144467     DOI: 10.1016/0008-8749(90)90165-n

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  23 in total

Review 1.  Current status review: the severe combined immunodeficient (SCID) mouse: xenogeneic-SCID chimeras in the investigation of human autoimmune disease.

Authors:  P C Taylor
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

2.  Optical techniques for tracking multiple myeloma engraftment, growth, and response to therapy.

Authors:  Judith M Runnels; Alicia L Carlson; Costas Pitsillides; Brian Thompson; Juwell Wu; Joel A Spencer; John M J Kohler; AbdelKareem Azab; Anne-Sophie Moreau; Scott J Rodig; Andrew L Kung; Kenneth C Anderson; Irene M Ghobrial; Charles P Lin
Journal:  J Biomed Opt       Date:  2011 Jan-Feb       Impact factor: 3.170

Review 3.  Mycobacterium avium subsp. paratuberculosis in Veterinary Medicine.

Authors:  N B Harris; R G Barletta
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

Review 4.  Natural killer cell memory.

Authors:  Silke Paust; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2011-06       Impact factor: 25.606

5.  Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer.

Authors:  Kabir A Khan; José L Ponce de Léon; Madeleine Benguigui; Ping Xu; Annabelle Chow; William Cruz-Muñoz; Shan Man; Yuval Shaked; Robert S Kerbel
Journal:  NPJ Breast Cancer       Date:  2020-07-20

6.  MDL 74,968, a new acyclonucleotide analog: activity against human immunodeficiency virus in vitro and in the hu-PBL-SCID.beige mouse model of infection.

Authors:  C G Bridges; D L Taylor; P S Ahmed; T M Brennan; J M Hornsperger; J F Navé; P Casara; A S Tyms
Journal:  Antimicrob Agents Chemother       Date:  1996-05       Impact factor: 5.191

7.  The human fetal lung xenograft: validation as model of microvascular remodeling in the postglandular lung.

Authors:  Monique E De Paepe; Sharon Chu; Susan Hall; Nicholas E Heger; Chris Thanos; Quanfu Mao
Journal:  Pediatr Pulmonol       Date:  2012-07-18

8.  Enhanced tumorigenicity of an Epstein-Barr virus-transformed lymphoblastoid cell line is associated with a unique 1:18 chromosomal translocation and decreased expression of lymphocyte function associated antigen-1a (CD11A).

Authors:  G R Picchio; J I Cohen; E R Wyatt; D E Mosier
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice.

Authors:  M L Schito; J R Barta
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

10.  Experimental sialodacryoadenitis virus infection in severe combined immunodeficient mice.

Authors:  D H Percy; K L Williams; B A Croy
Journal:  Can J Vet Res       Date:  1991-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.